Latest news
Probe Scientific announces completion of funding round
8 September 2011
The Board confirmed that it closed an investment round from existing shareholders and directors. This allows Probe to develop new partnerships and applications and allows it to conclude existing licence deals in a range of territories/markets
New study in major UK hospital
1 June 2011
Probe Scientific is pleased to announce that ethics approval has been received for a new study in a major UK hospital. The study will focus on the combined performance of Probe’s MicroEye® and novel sensing technology
Exciting commercial and clinical interest in continuous Glucose monitoring at SCCM San Diego Jan 11
28 January 2011
Probe held meetings with a number of commercial companies who are interested in using Probe’s technology. Discussions ranged from those interested in specific applications or analytes to those interested in fully integrated multi analyte applications
Probe Scientific appoints a new Chairman
20 April 2009
Probe is please to announce the appointment of David George as Chairman. David brings with him significant industry experience and has the right skills to lead Probe to profitability and exit.
Key opinion leaders studies confirm previous market data
30 January 2009
Probe has recently completed third party key opinion leader studies in Europe and the USA.
Probe Scientific launches revolutionary MicroEye® system
9 November 2007
Probe Scientific has formally launched MicroEye®, a revolutionary device to solve clinical problems and enhance healthcare through more efficient and effective blood sampling.